Abstract:
The method includes storing a carotenoid pigment in a container that has an average spectral transmittance of 0.01 to 45.0% between a wavelength of 535 to 695 nm.
Abstract:
The present invention provides rapid disintegrating tablets in oral cavity having a shortened disintegration time in oral cavity as well as a sufficient hardness with compared to rapid disintegrating tablets of the prior art.The above objective is solved by a composition for rapid disintegrating tablets in oral cavity, wherein components (a) to (c) are contained in such manner that (a) saccharides consisting of a combination of mannitol and xylitol is 40 to 90 parts by weight; (b) the inorganic excipient is 1 to 30 parts by weight; and (c) the disintegrating agent is 5 to 40 parts by weight, provided that the total amount of (a), (b) and (c) is 100 parts by weight.
Abstract:
There is provided pet food comprising astaxanthin and/or an ester thereof as an active component and having an effect of deodorizing excrement such as urine and feces, effects of improving sleep, sensibility such as perception and cognition, and visual sense, and an effect of treating, improving or preventing diabetes and diabetic complications. The pet food can deodorize excrement such as urine and feces, improve sleep, sensibility such as perception and cognition, and visual sense, and treat, improve or prevent diabetes and diabetic complications.
Abstract:
There is provided pet food comprising astaxanthin and/or an ester thereof as an active component and having an effect of deodorizing excrement such as urine and feces, effects of improving sleep, sensibility such as perception and cognition, and visual sense, and an effect of treating, improving or preventing diabetes and diabetic complications. The pet food can deodorize excrement such as urine and feces, improve sleep, sensibility such as perception and cognition, and visual sense, and treat, improve or prevent diabetes and diabetic complications.
Abstract:
An object of the invention is to provide a gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester. Abnormal gene expression due to, for example, oxidative stress can be treated, improved, and/or prevented, and diseases caused by the abnormal gene expression can be treated, improved, and/or prevented. A gene expression regulating agent which includes astaxanthin and/or its ester as an effective ingredient; and a food and drink having an effect of regulating gene expression which includes astaxanthin and/or its ester are provided and are useful for treating, improving, and/or preventing the symptom caused by the abnormal gene expression, that is, excessive expression or suppression of expression.
Abstract:
There can be provided a positive electrode active material for a secondary battry which is excellent in the charging and discharging cycle characteristics so that it retains high battery capacity that is comparable to the hitherto known LiNiO2 even by increasing the number of cycle, which has an improved cycle property (stability) at high temperature and which is a complex oxide represented by the general formula (I)LiyNi1-xCox1Mx2O2 nullnull(I)(wherein M represents at least one element selected from the group consisting of Al, Fe, Mn and B, y represents 0.9nullynull1.3, x represents 0
Abstract translation:可以提供一种充电和放电循环特性优异的二次电抗器用正极活性物质,使得即使通过增加循环次数也能保持与现有已知的LiNiO2相当的高电池容量,其具有改善的 (I)表示的复合氧化物,其中在线式(I)中,式(I)表示的复合氧化物,其中在线式中,Li + >(其中M表示选自Al,Fe,Mn和B中的至少一种元素,y表示0.9 <= y <= 1.3,x表示0
Abstract:
There is provided pet food comprising astaxanthin and/or an ester thereof as an active component and having an effect of deodorizing excrement such as urine and feces, effects of improving sleep, sensibility such as perception and cognition, and visual sense, and an effect of treating, improving or preventing diabetes and diabetic complications. The pet food can deodorize excrement such as urine and feces, improve sleep, sensibility such as perception and cognition, and visual sense, and treat, improve or prevent diabetes and diabetic complications.
Abstract:
The present invention relates to a stable astaxanthin-containing powdery composition which is obtained by drying a suspension containing a ground Haematococcus alga containing astaxanthin, a surfactant, an antioxidant, an excipient and water and to a process for preparing the same.According to the present invention, there can be provided an astaxanthin-containing powdery composition wherein astaxanthin present in Haematococcus alga has been efficiently stabilized to improve its storage stability for a long term and which is excellent in flowability as a powder, easy to handle and can be easily subjected to solvent extraction without degrading the astaxanthin.
Abstract:
There is incorporated as a stabilizer into a halogen-containing resin a complex hydroxide salt represented by the formula �Al.sub.2 (Li.sub.(1-x).M.sub.x)(OH).sub.6 !.sub.n (A.sup.-n).sub.1+x.mH.sub.2 O wherein A is an inorganic or organic anion, M is Mg and/or Zn, n is a valence number of anion A, m is 0 or positive number, and x satisfies the expression of 0.01.ltoreq.x
Abstract:
The object of the present invention is to prepare a calcium hydrogen phosphate that has excellent binding properties, a large oil adsorption capacity and a specific surface area, and is therefore suitable as an excipient.A scale-like calcium hydrogen phosphate is prepared by reacting phosphoric acid with an alkaline calcium compound such as quick lime, in the presence of a multivalent organic acid with coordinating ability, such as citric acid, to obtain a columnar calcium hydrogen phosphate, and then hydrothermally treating the obtained columnar calcium hydrogen phosphate at a temperature of 60.degree. C. or higher.